Cypress, CANCT06924320Now EnrollingIRB Ready

Obesity and Obesity-related Medical Conditions Clinical Trial in Cypress, CA

Access cutting-edge obesity and obesity-related medical conditions treatment through this clinical trial at a research site in Cypress. Study-provided care at no cost to qualified participants.

Sponsored by Pfizer

Quick Self-Assessment

See if you qualify for this Cypress location

Preparing your pre-screening questions…

Expert Care in Cypress

Access obesity and obesity-related medical conditions specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related obesity and obesity-related medical conditions treatment provided free

Apply for This Cypress Location

Check if you qualify for this obesity and obesity-related medical conditions clinical trial in Cypress, CA

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Cypress

    Convenient for CA residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Cypress site if eligible
  4. 4Begin participation

About This Obesity and Obesity-related Medical Conditions Study in Cypress

This study is designed to test how well the combination of MET233 with MET097 works to treat individuals with obesity or overweight with or without diabetes.

Sponsor: Pfizer

Who Can Participate

Inclusion Criteria

Adult males or females aged 18 to 75 years (inclusive) at the time of screening.
BMI ≥27.0 kg/m2 and ≤38.0 kg/m2 (inclusive) at Screening for Parts A, B, and C, and ≥30.0 kg/m2 and ≤45.0 kg/m2 (inclusive) at Screening for Parts D and E. Have a BMI ≥27.0 kg/m2 and ≤45.0 kg/m2 (inclusive) at Screening for Parts G.
Participants must be in generally stable health, as determined by the investigator based on medical history, physical examination (including vital signs), laboratory evaluations, and electrocardiogram (ECG).
Participants must have no clinically significant diseases or clinically significant findings on the physical examination (including vital signs), laboratory evaluations, and electrocardiogram (ECG).
Participants in Parts C must not have clinically significant diseases except type 2 diabetes mellitus (T2DM), sleep apnea, well-controlled hypertension, and/or dyslipidemia.
Participants in Parts E and G must not have any clinically significant diseases except hypertension, dyslipidemia, and/or a clinical diagnosis of sleep apnea.
Willing and able to comply with all scheduled study visits, procedures, and required assessments.
Women of childbearing potential must be willing to comply with protocol-specified contraceptive requirements and must not plan to become pregnant during the study.

Exclusion Criteria

Female who is lactating or who is pregnant according to the pregnancy test at Screening or on Day 1. Unwillingness or inability to comply with protocol-specified contraceptive requirements.
Clinically significant abnormalities in laboratory results in the opinion of the investigator, increase risk or interfere with study participation.
Seated blood pressure higher than 160/100 mmHg at the Screening visit or prior to the first study drug administration.
Elevated resting pulse greater than 100 beats per minute at Screening visit or prior to the first study drug administration.
Estimated glomerular filtration rate (eGFR) \<80 mL/min at the Screening visit.
Diagnosis of Type 1 diabetes.
For Part A, Part B, Part D, Part E and Part G: Diagnosis of T2DM or glycated hemoglobin (HbA1c) \> 6.4% or fasting plasma glucose \>126 mg/dL at the Screening visit or history of taking any medications to lower glucose.
For Part A, Part B and Part D: Participant reported weight-related comorbidity, including sleep apnea and cardiovascular disease.
Use of prohibited prescription or non-prescription medications, supplements, or investigational products within protocol-defined washout periods.
History or presence of clinically significant gastrointestinal, endocrine, respiratory, renal, hepatic, hematologic, neurologic, cardiovascular, psychiatric, immunologic, or other systemic diseases, except where explicitly permitted by the protocol.
Personal or family history of medullary thyroid carcinoma, multiple endocrine neoplasia syndrome, pancreatitis, or pancreatic cancer.
History of acute or chronic pancreatitis or pancreatic cancer.
Participation in a weight loss program with or without pharmacotherapy during the 3 months prior to study administration or plans to do so.
History of bariatric or weight-loss surgery.
Clinically significant psychiatric illness that may interfere with study participation or safety.
Screening assessments indicative of moderate to severe depression.
History of drug or alcohol abuse or dependence within the past 2 years.

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Cypress?

Yes, this clinical trial (NCT06924320) has an active research site in Cypress, CA that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Obesity and Obesity-related Medical Conditions Treatment Options in Cypress, CA

If you're searching for obesity and obesity-related medical conditions treatment options in Cypress, CA, this clinical trial (NCT06924320) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Cypress research site is actively enrolling participants for this clinical trial. You'll receive care from experienced obesity and obesity-related medical conditions specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all obesity and obesity-related medical conditions clinical trials near you to find additional studies recruiting in your area.

More Obesity Trials in Cypress, CA

See all obesity clinical trials recruiting in Cypress — not just this study.

Browse Obesity Trials in Cypress →

Browse More Trials by Condition

Obesity TrialsErectile Dysfunction TrialsInterstitial Cystitis TrialsMyalgic Encephalomyelitis TrialsAll Conditions →

Ready to Join in Cypress?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Cypress, CA